USE OF ANTICOAGULANT IN COVID-19 PATIENTS AT PKU MUHAMMADIYAH GAMPING HOSPITAL YOGYAKARTA

• Príomhchruthaitheoirí: Nurhasani - (Údar), Woro supadmi (Údar), Endang Yuniarti (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Universitas Muhammadiyah Magelang, 2023-06-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Based on WHO data, there is about 14% average of patients who suffer from a severe level of Covid-19 disease and 5% of patients admitted to the ICU (Intensive Care Unit) are known to have symptoms of thromboembolism and coagulopathy disorders. The current management of Covid-19 therapy requires hepa...